{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:56:47Z","timestamp":1790211407234,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,27]]},"DOI":"10.7759\/cureus.22645","type":"journal-article","created":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T10:52:16Z","timestamp":1645959136000},"source":"Crossref","is-referenced-by-count":5,"title":["Medical Therapy, Radiofrequency Ablation, or Cryoballoon Ablation as First-Line Treatment for Paroxysmal Atrial Fibrillation: Interpreting Efficacy Through the Shiny Method"],"prefix":"10.7759","author":[{"given":"Sabrina","family":"Trippoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Di Spazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Chiumente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Messori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"384","author":"Andrade JG","year":"2021","unstructured":"Andrade JG, Wells GA, Deyell MW, et al.. Cryoablation or drug therapy for initial treatment of atrial fibrillation. N Engl J Med. 2021, 384:305-15. 10.1056\/NEJMoa2029980","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon ablation as initial therapy for atrial fibrillation","volume":"384","author":"Wazni OM","year":"2021","unstructured":"Wazni OM, Dandamudi G, Sood N, et al.. Cryoballoon ablation as initial therapy for atrial fibrillation. N Engl J Med. 2021, 384:316-24. 10.1056\/NEJMoa2029554","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.467","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial","volume":"311","author":"Morillo CA","year":"2014","unstructured":"Morillo CA, Verma A, Connolly SJ, et al.. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA. 2014, 311:692-700. 10.1001\/jama.2014.467","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.21.2634","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial","volume":"293","author":"Wazni OM","year":"2005","unstructured":"Wazni OM, Marrouche NF, Martin DO, et al.. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. 2005, 293:2634-40. 10.1001\/jama.293.21.2634","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euab029","article-title":"Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation","volume":"23","author":"Kuniss M","year":"2021","unstructured":"Kuniss M, Pavlovic N, Velagic V, et al.. Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation. Europace. 2021, 23:1033-41. 10.1093\/europace\/euab029","journal-title":"Europace"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113566","article-title":"Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation","volume":"367","author":"Cosedis Nielsen J","year":"2012","unstructured":"Cosedis Nielsen J, Johannessen A, Raatikainen P, et al.. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med. 2012, 367:1587-95. 10.1056\/NEJMoa1113566","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-021-01308-8","article-title":"IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves","volume":"21","author":"Liu N","year":"2021","unstructured":"Liu N, Zhou Y, Lee JJ. IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves. BMC Med Res Methodol. 2021, 21:111. 10.1186\/s12874-021-01308-8","journal-title":"BMC Med Res Methodol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19422","article-title":"Synthetizing published evidence on survival by reconstruction of patient-level data and generation of a multi-trial Kaplan-Meier curve","volume":"13","author":"Messori A","year":"2021","unstructured":"Messori A. Synthetizing published evidence on survival by reconstruction of patient-level data and generation of a multi-trial Kaplan-Meier curve. Cureus. 2021, 13:e19422. 10.7759\/cureus.19422","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.2022141","article-title":"A preliminary estimate of survival gain and cost-effectiveness of CAR-T in adult patients with acute lymphoblastic leukemia [In Press]","author":"Messori A","year":"2021","unstructured":"Messori A, Rivano M, Mengato D, Cancanelli L, Di Spazio L, Chiumente M. A preliminary estimate of survival gain and cost-effectiveness of CAR-T in adult patients with acute lymphoblastic leukemia [In Press]. Leuk Lymphoma. 2021, 1-4. 10.1080\/10428194.2021.2022141","journal-title":"Leuk Lymphoma"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19893","article-title":"Efficacy of immune checkpoint inhibitors in patients with mismatch repair-deficient or microsatellite instability-high metastatic colorectal cancer: analysis of three phase-II trials","volume":"13","author":"Cancanelli L","year":"2021","unstructured":"Cancanelli L, Rivano M, Di Spazio L, Chiumente M, Mengato D, Messori A. Efficacy of immune checkpoint inhibitors in patients with mismatch repair-deficient or microsatellite instability-high metastatic colorectal cancer: analysis of three phase-II trials. Cureus. 2021, 13:e19893. 10.7759\/cureus.19893","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21065","article-title":"The degree of programmed death-ligand 1 (PD-L1) positivity as a determinant of outcomes in metastatic triple-negative breast cancer treated with first-line immune checkpoint inhibitors","volume":"14","author":"Di Spazio L","year":"2022","unstructured":"Di Spazio L, Rivano M, Cancanelli L, Chiumente M, Mengato D, Messori A. The degree of programmed death-ligand 1 (PD-L1) positivity as a determinant of outcomes in metastatic triple-negative breast cancer treated with first-line immune checkpoint inhibitors. Cureus. 2022, 14:e21065. 10.7759\/cureus.21065","journal-title":"Cureus"},{"key":"ref12","article-title":"Current treatments for advanced or metastatic osteosarcoma: indirect comparisons based on individual patient data reconstructed retrospectively from 5 trials [In Press]","author":"Messori A","year":"2022","unstructured":"Messori A. Current treatments for advanced or metastatic osteosarcoma: indirect comparisons based on individual patient data reconstructed retrospectively from 5 trials [In Press]. J Bone Res. 2022,","journal-title":"J Bone Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2203067","article-title":"Medical therapy, radiofrequency ablation or cryoballoon ablation as first-line treatment for paroxysmal atrial fibrillation: interpreting efficacy through restricted mean survival time and network meta-analysis","volume":"22","author":"Messori A","year":"2021","unstructured":"Messori A, Bartoli L, Ferracane E, Trippoli S. Medical therapy, radiofrequency ablation or cryoballoon ablation as first-line treatment for paroxysmal atrial fibrillation: interpreting efficacy through restricted mean survival time and network meta-analysis. Rev Cardiovasc Med. 2021, 22:557-61. 10.31083\/j.rcm2203067","journal-title":"Rev Cardiovasc Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati A","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al.. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009, 339:b2700. 10.1136\/bmj.b2700","journal-title":"BMJ"},{"key":"ref15","unstructured":"R Foundation for Statistical Computing. A language and environment for statistical computing. (2020). Accessed: February 13, 2022: https:\/\/www.R-project.org\/."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2021-319496","article-title":"Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis","volume":"107","author":"Imberti JF","year":"2021","unstructured":"Imberti JF, Ding WY, Kotalczyk A, et al.. Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis. Heart. 2021, 107:1630-6. 10.1136\/heartjnl-2021-319496","journal-title":"Heart"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2021.09.003","article-title":"Meta-analysis of catheter ablation as first-line therapy for paroxysmal atrial fibrillation","volume":"162","author":"Kheiri B","year":"2022","unstructured":"Kheiri B, Nazer B. Meta-analysis of catheter ablation as first-line therapy for paroxysmal atrial fibrillation. Am J Cardiol. 2022, 162:199-200. 10.1016\/j.amjcard.2021.09.003","journal-title":"Am J Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/87681-medical-therapy-radiofrequency-ablation-or-cryoballoon-ablation-as-first-line-treatment-for-paroxysmal-atrial-fibrillation-interpreting-efficacy-through-the-shiny-method","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:00Z","timestamp":1707507540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/87681-medical-therapy-radiofrequency-ablation-or-cryoballoon-ablation-as-first-line-treatment-for-paroxysmal-atrial-fibrillation-interpreting-efficacy-through-the-shiny-method"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,27]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.22645","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,27]]}}}